These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1036504)

  • 1. Effects of pituitary graft and 2-bromo-alpha-ergocryptine on mammary DNA synthesis in mice in relation to mammary tumorigenesis.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1976 May; 56(5):1055-6. PubMed ID: 1036504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of mammary gland DNA synthesis on carcinogen-induced mammary tumorigenesis in rats.
    Nagasawa H; Yanai R; Taniguchi H
    Cancer Res; 1976 Jul; 36(7 PT 1):2223-6. PubMed ID: 945123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of estrogen and prolactin in spontaneous mammary tumorigenesis of the mouse.
    Welsch CW
    J Toxicol Environ Health Suppl; 1976; 1():161-75. PubMed ID: 1036505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression by Nocardia rubra cell wall skeleton mammary DNA synthesis, plasma prolactin level, and spontaneous mammary tumorigenesis in mice.
    Nagasawa H; Yanai R; Azuma I
    Cancer Res; 1978 Jul; 38(7):2160-2. PubMed ID: 657146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oestrogen and/or pituitary grafts on nucleic acid synthesis in the mammary glands of lactating mice.
    Nagasawa H; Yanai R
    J Endocrinol; 1978 Jun; 77(3):319-23. PubMed ID: 660075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of varying photoperiods on mammary morphology, DNA synthesis, and hormone profile in female rats.
    Mhatre MC; Shah PN; Juneja HS
    J Natl Cancer Inst; 1984 Jun; 72(6):1411-6. PubMed ID: 6427503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary gland in rats.
    Gräf KJ; Horowski R; Etreby MF
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):267-78. PubMed ID: 325978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin and the development and progression of early neoplastic mammary gland lesions.
    Welsch CW
    Cancer Res; 1978 Nov; 38(11 Pt 2):4054-8. PubMed ID: 698954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of spontaneous mammary tumorigenesis by temporal inhibition of prolactin secretion in rats at young ages.
    Nagasawa H; Morii S
    Cancer Res; 1981 May; 41(5):1935-7. PubMed ID: 7214361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of the action of prolactin on [3H]-thymidine incorporation into DNA in mammary gland explants from virgin mice.
    Rillema JA; Foley KA
    Horm Metab Res; 1983 Aug; 15(8):385-8. PubMed ID: 6352447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of prenatal or neonatal administration of 2-bromo-alpha-ergocryptine on pituitary prolactin secretion and normal and neoplastic mammary growth in adult mice.
    Nagasawa H; Yanai R
    J Endocrinol Invest; 1978 Jul; 1(3):273-6. PubMed ID: 583157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent studies on functions and control of prolactin secretion in rats.
    Meites J; Lu KH; Wuttke W; Welsch CW; Nagasawa H; Quadri SK
    Recent Prog Horm Res; 1972; 28():471-526. PubMed ID: 4569231
    [No Abstract]   [Full Text] [Related]  

  • 14. Oestrogen and progesterone receptors in mammary tumours of male SHN mice grafted with pituitaries in comparison with females.
    Nagasawa H; Yamamoto K; Furuichi R; Sakamoto S
    Anticancer Res; 1994; 14(1A):61-5. PubMed ID: 8166457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of early preneoplastic lesions of the mammary gland.
    Welsch CW
    Cancer Res; 1976 Jul; 36(7 PT 2):2621-5. PubMed ID: 1277169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cause of species differences in mammary tumourigenesis: significance of mammary gland DNA synthesis.
    Nagasawa H
    Med Hypotheses; 1979 Apr; 5(4):499-510. PubMed ID: 223022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cleaved form of prolactin in the mouse pituitary gland: identification and comparison of in vitro synthesis and release in strains with high and low incidences of mammary tumors.
    Sinha YN; Gilligan TA
    Endocrinology; 1984 Jun; 114(6):2046-53. PubMed ID: 6723574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine.
    Welsch CW; Adams C; Lambrecht LK; Hassett CC; Brooks CL
    Br J Cancer; 1977 Mar; 35(3):322-8. PubMed ID: 576837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calories, parity, and prolactin influence mammary epithelial kinetics and differentiation and alter mouse mammary tumor risk.
    Engelman RW; Day NK; Good RA
    Cancer Res; 1993 Mar; 53(5):1188-94. PubMed ID: 8382558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison.
    Welsch CW; Lambrecht LK; Hassett CC
    J Natl Cancer Inst; 1977 Apr; 58(4):1135-8. PubMed ID: 576623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.